There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

ABC News' Dr. Tara Narula breaks down a potential non-surgical breakthrough as the FDA fast-tracks review of a ...

A new bladder cancer device called TAR-200 kept most patients cancer-free and surgery-free in a trial, with few side effects ...

Deion Sanders announces he battled bladder cancer and is now cancer-free after tumor removal surgery, while doctors share ...

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

Bladder cancer survivors have spoken out on the 'red flag' warning sign and 'most common' symptom they all experienced before ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with ...

Colorado Buffaloes head football coach Deion Sanders is "loving life" following his quiet, months-long battle with bladder ...

New trial results reveal enfortumab vedotin and pembrolizumab significantly improve survival for muscle-invasive bladder ...

Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

Sanders said during a news conference on Monday that the cancer was found when he went for a precautionary annual CT scan; he has a history of blood clots in his legs. Bladder cancer is more common in ...